The <scp>BACE</scp> ‐1 inhibitor <scp>CNP</scp> 520 for prevention trials in Alzheimer's disease
2018 · EMBO Molecular Medicine · 167 citations
https://doi.org/10.15252/emmm.201809316
U
Ulf Neumann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
5.3K
Citations
42
h-index
84
i10-index
Ulf Neumann is an academic researcher from Maastricht University Medical Centre. The author has contributed to research in topics: Alzheimer's disease research and treatments & Computational Drug Discovery Methods & Cholinesterase and Neurodegenerative Diseases. The author has an h-index of 42, co-authored 123 publications.
ORCID: 0000-0001-6680-9177Papers by this author
worksA novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice
2015 · Molecular Neurodegeneration · 109 citations
https://doi.org/10.1186/s13024-015-0033-8
Pharmacological BACE1 and BACE2 inhibition induces hair depigmentation by inhibiting PMEL17 processing in mice
2016 · Scientific Reports · 66 citations
https://doi.org/10.1038/srep21917
Tau deletion reduces plaque‐associated <scp>BACE</scp> 1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease
2019 · The EMBO Journal · 41 citations
https://doi.org/10.15252/embj.2019102345
Hydroxyproline-containing collagen analogs trigger the release and activation of collagen-sequestered proMMP-2 by competition with prodomain-derived peptide P33-42
2011 · Fibrogenesis & Tissue Repair · 39 citations
https://doi.org/10.1186/1755-1536-4-1
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
2023 · Journal of Neuroinflammation · 14 citations
https://doi.org/10.1186/s12974-022-02671-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat